Publicaciones en colaboración con investigadores/as de Hospital de Cruces (5)

2022

  1. Effects of everolimus plus minimized tacrolimus on kidney function in liver transplantation: REDUCE, a prospective, randomized controlled study

    Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, Vol. 114, Núm. 6, pp. 335-342

2017

  1. Efficacy and safety of daclatasvir-based antiviral therapy in hepatitis C virus recurrence after liver transplantation. Role of cirrhosis and genotype 3. A multicenter cohort study

    Transplant International, Vol. 30, Núm. 10, pp. 1041-1050

2009

  1. Pamidronate in the prevention of bone loss after liver transplantation: A randomized controlled trial

    Transplant International, Vol. 22, Núm. 2, pp. 198-206

2005

  1. An open, randomized, multicenter clinical trial of oral tacrolimus in liver allograft transplantation: A comparison of dual vs. triple drug therapy

    Liver Transplantation, Vol. 11, Núm. 5, pp. 515-524

2002

  1. Tacrolimus is effective in both dual and triple regimens after liver transplantation

    Transplantation Proceedings